[1]
Aritajati, T., Chayakul, C. and Tongyoo, S. 2022. Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study). Clinical Critical Care. 30, (Mar. 2022), 2022:e0003. DOI:https://doi.org/10.54205/ccc.v30.254966.